A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma

医学 DLCO公司 安慰剂 甲氨蝶呤 内科学 硬皮病(真菌) 扩散能力 随机对照试验 胃肠病学 外科 病理 肺 肺功能 替代医学 接种
作者
Janet Elizabeth Pope,Nicholas Bellamy,James R. Seibold,Murray G Baron,Michael H. Ellman,Simon Carette,C. Douglas Smith,Ian M. Chalmers,Paul Hong,David O'Hanlon,Elżbieta Kamińska,Janet Markland,John T. Sibley,Luis Jose Catoggio,Daniel E. Furst
出处
期刊:Arthritis & Rheumatism [Wiley]
卷期号:44 (6): 1351-1358 被引量:457
标识
DOI:10.1002/1529-0131(200106)44:6<1351::aid-art227>3.0.co;2-i
摘要

OBJECTIVE: Early diffuse scleroderma (systemic sclerosis; SSc) has no proven treatment. This study was undertaken to examine the efficacy of methotrexate (MTX) in improving the skin and other disease parameters in early diffuse SSc. METHODS: Seventy-one patients with diffuse SSc of <3 years' duration were enrolled in a multicenter, randomized, placebo-controlled, double-blind trial. Thirty-five patients were treated with MTX and 36 with placebo. Treatment was administered for 12 months. The primary outcome measures were skin score (as determined with 2 different indices) and physician global assessment. RESULTS: At baseline, there were no statistically significant differences in skin scores, carbon monoxide diffusing capacity (DLco), physician global assessment, or other secondary outcome measurements between the 2 treatment groups. At study completion, results slightly favored the MTX group (mean +/- SEM modified Rodnan skin score 21.4+/-2.8 in the MTX group versus 26.3+/-2.1 in the placebo group [P < 0.17]; UCLA skin score 8.8+/-1.2 in the MTX group versus 11.0+/-0.9 in the placebo group [P < 0.15]; DLco in the MTX group 75.7+/-4.6 versus 61.8+/-3.4 in the placebo group [P < 0.2]). In addition, physician global assessment results favored MTX (P < 0.035), whereas patient global assessment did not differ significantly between groups. When between-group differences for changes in scores from baseline to 12 months were examined using intent-to-treat methodology, MTX appeared to have a favorable effect on skin scores (modified Rodnan score -4.3 in the MTX group versus 1.8 in the placebo group [P < 0.009]; UCLA score -1.2 in the MTX group versus 1.2 in the placebo group [P < 0.02]), but differences in the degree of change in the DLco and physician global assessment were not significant. For the UCLA skin score, these differences in results were not statistically significant after adjustment for baseline differences in sex distribution and steroid use. Dropout rates were similar in the 2 groups. CONCLUSION: Although results of this trial demonstrated a trend in favor of MTX versus placebo in the treatment of early diffuse SSc, the between-group differences were small and the power to rule out false-negative results was only 50%. Our findings do not provide evidence that MTX is significantly effective in the treatment of early diffuse SSc.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
mbl2006完成签到 ,获得积分10
刚刚
1秒前
慕青的应助被白白采纳,获得10
1秒前
华安完成签到,获得积分10
1秒前
LT发布了新的文献求助10
1秒前
科研通AI6.4的应助被抗体小王采纳,获得10
1秒前
chenyiyi发布了新的文献求助20
2秒前
顾矜的应助被湛蓝的天空采纳,获得30
2秒前
orixero的应助被成就的沛菡采纳,获得10
3秒前
桃里里完成签到,获得积分10
3秒前
小易完成签到,获得积分10
4秒前
嘴遁老铁叽完成签到,获得积分10
4秒前
沉默红牛完成签到,获得积分10
4秒前
ming完成签到 ,获得积分10
4秒前
4秒前
5秒前
淼淼发布了新的文献求助10
5秒前
坦率的山菡完成签到,获得积分10
5秒前
morris发布了新的文献求助10
5秒前
孙佳乐完成签到 ,获得积分10
5秒前
5秒前
嗒嗒完成签到,获得积分10
6秒前
6秒前
隐形曼青的应助被QQ采纳,获得10
6秒前
积极妙菡关注了科研通微信公众号
7秒前
Eason完成签到,获得积分10
7秒前
7秒前
八森木完成签到,获得积分0
8秒前
打打的应助被Waboss采纳,获得10
8秒前
sunnymoon发布了新的文献求助10
9秒前
赵晋杰完成签到,获得积分20
9秒前
9秒前
Yyy发布了新的文献求助10
9秒前
sunnymoon发布了新的文献求助10
9秒前
9秒前
DDDDn完成签到 ,获得积分10
10秒前
sunnymoon发布了新的文献求助10
10秒前
10秒前
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161320
求助须知:如何正确求助?哪些是违规求助? 9556074
关于积分的说明 21732157
捐赠科研通 7751456
什么是DOI,文献DOI怎么找? 3427537
关于科研通互助平台的介绍 2552583
邀请新用户注册赠送积分活动 2471992